Regional variation and adherence to guidelines for drug treatment of asthma

European Journal of Clinical Pharmacology

Volumn 66, Issue 2, 2010, Pages 187-198

  Arnlind, Marianne Heibert ^a   Wettermark, Björn ^b   Nokela, Mika ^a,b   Hjemdahl, Paul ^b   Rehnberg, Clas ^a   Jonsson, Eva Wikström ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Asthma; Drug utilization; Economics; Guidelines; Pharmaceuticals; Prescribing

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LONG ACTING DRUG; SHORT ACTING DRUG;

ADULT; ARTICLE; ASTHMA; DRUG COST; DRUG UTILIZATION; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE QUALITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; REGISTER; REIMBURSEMENT; SWEDEN;

ADOLESCENT; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; DRUG COMBINATIONS; DRUG UTILIZATION; FEES, PHARMACEUTICAL; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MODELS, STATISTICAL; NATIONAL HEALTH PROGRAMS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRESCRIPTION DRUGS; REGISTRIES; SEX CHARACTERISTICS; SWEDEN; YOUNG ADULT;

EID: 76949096299     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-009-0731-7     Document Type: Article

References (63)

1. PG Burney C Luczynska S Chinn D Jarvis 1994 The European community respiratory health survey Eur Respir J 7 5 954 960 1:STN:280: DyaK2czis12jtQ%3D%3D 8050554
2. Läkemedelsverket Medical Products Agency (2007) Farmakologisk behandling vid astma-2007. Tryckt version. 2007(18) Temanummer
3. J Bousquet TJ Clark S Hurd N Khaltaev C Lenfant P O'Byrne, et al. 2007 GINA guidelines on asthma and beyond Allergy 62 2 102 112 10.1111/j.1398-9995. 2006.01305.x 1:STN:280:DC%2BD2s%2FpvFKjsw%3D%3D 17298416 (Pubitemid 46091634)
4. F Henriksson C Hjortsberg C Rehnberg 1999 Pharmaceutical expenditure in Sweden Health Policy 47 2 125 144 10.1016/S0168-8510(99)00016-0 1:STN:280:DyaK1MzjvFSrug%3D%3D 10538288 (Pubitemid 29241790)
5. Moise P, Docteur E (2007) OECD Health Working Papers No. 28. Pharmaceutical pricing and reimbursement in Sweden:13 September 2007. Available at: htttp://www.olis.oecd.org/olis/2007doc.nsf/FREDATCORPLOOK/NT00002E52/ FILE/JTO3231887.PDF (assessed 2 Feb 2008)
6. Socialstyrelsen (2008) Läkemedelsförsäljningen I Sverige-analys och prognos. Stockholm
7. Socialstyrelsen (2007) Läkemedelsförsäljningen I Sverige-analys och prognos (September 2007). Stockholm
8. Brodin H (1987) Regional variations in pharmaceutical consumption in Sweden. Linköping University, Linköping
9. UG Gerdtham P Hertzman B Jonsson G Boman 1996 Impact of inhaled corticosteroids on acute asthma hospitalization in Sweden 1978 to 1991 Med Care 34 12 1188 1198 10.1097/00005650-199612000-00004 1:STN:280:DyaK2s7it1ansA%3D%3D 8962585 (Pubitemid 126433216)
10. D Haupt K Krigsman JL Nilsson 2008 Medication persistence among patients with asthma/COPD drugs Pharm World Sci 30 5 509 514 10.1007/s11096-008-9197-4 18247154
11. K Krigsman J Moen JL Nilsson L Ring 2007 Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period J Clin Pharm Ther 32 6 603 611 10.1111/j.1365-2710.2007.00866.x 1:STN:280:DC%2BD2snosl2jug%3D%3D 18021338 (Pubitemid 350135114)
12. I Eckerlund UG Gerdtham 1998 Econometric analysis of variation in cesarean section rates. A cross-sectional study of 59 obstetrical departments in Sweden Int J Technol Assess Health Care 14 4 774 787 10.1017/S0266462300012071 1:STN:280:DyaK1M7gt1ymsA%3D%3D 9885466
13. A Gillissen 2007 Patients' adherence in asthma J Physiol Pharmacol 58 Suppl 5 205 222
14. I Hartz S Sakshaug K Furu A Engeland AE Eggen I Njolstad, et al. 2007 Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption - an individual-level prescription database study BMC Clin Pharmacol 7 14 10.1186/1472-6904-7-14 18053228 (Pubitemid 351248077)
15. B Wettermark N Hammar C MichaelFored A Leimanis P Otterblad Olausson U Bergman, et al. 2007 The new Swedish prescribed drug register-opportunities for pharmacoepidemiological research and experience from the first six months Pharmacoepidemiol Drug Saf 16 7 726 735 10.1002/pds.1294 16897791 (Pubitemid 47180362)
16. MH Arnlind M Nokela C Rehnberg EW Jonsson 2006 The relationship between pharmaceutical costs, disease severity, and health-related quality of life in asthmatics in Swedish primary care J Asthma 43 8 585 591 10.1080/ 02770900600878305 17050222 (Pubitemid 44581252)
17. F Sjöqvist U Bergman ML Dahl 2002 eaDatcaSeWDI. Drug and therapeutics committees: a Swedish experience WHO Drug Inf 16 207 213
18. B Wettermark B Godman K Andersson LL Gustafsson A Haycox V Bertele 2008 Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe Pharmacoeconomics 26 7 537 550 10.2165/00019053-200826070-00001 18563945 (Pubitemid 351871549)
19. B Godman B Wettermark M Hoffmann K Andersson A Haycox LL Gustafsson 2009 Swedish experience in ambulatory care with multifaceted national and regional drug reforms and initiatives: global relevance. Expert Review Pharmacoeconomics Outcomes Res 9 1 65 83 10.1586/14737167.9.1.65
20. A Anell 2005 Swedish healthcare under pressure Health Econ 14 Suppl 1 S237 S254 10.1002/hec.1039 16161198 (Pubitemid 41404327)
21. Socialdepartementet (2005) Socialdepartementet förordning (2005:363) om läkemedelsregister hos Socialstyrelsen. Stockholm
22. World Health Organization (2005) Guidelines for ATC classification an DDD assignment. WHO Collaborating Centre for Drug Statistics Methodology. Available at: www.whocc.no. WHO, Oslo
23. World Health Organization (2007) Guidelines for ATC classification and DDD assignment. WHO Collaborationg Center for Drug Statistics Methodology 2007: Available at: http://www.whocc.no/
24. World Health Organization (2003) Introduction to drug utilisation research, NLM classification WB 330. WHO, Oslo
25. J Hallas H Stovring 2006 Templates for analysis of individual-level prescription data Basic Clin Pharmacol Toxicol 98 3 260 265 10.1111/j.1742-7843. 2006.pto-257.x 1:CAS:528:DC%2BD28XjsVWmsLw%3D 16611200
26. G Bergstrom I Karlberg 2007 Decentralized responsibility for costs of outpatient prescription pharmaceuticals in Sweden. Assessment of models for decentralized financing of subsidies from a management perspective Health Policy 81 2-3 358 367 10.1016/j.healthpol.2006.07.006 16942815 (Pubitemid 46436193)
27. S Jansson A Anell 2006 The impact of decentralised drug-budgets in Sweden-a survey of physicians' attitudes towards costs and cost-effectiveness Health Policy 76 3 299 311 10.1016/j.healthpol.2005.06.002 16046026
28. Haaijer-Ruskamp F, HHoven J, Mol P (2004) A conceptual framework for constructing prescribing quality indicators: a poroposal. DURQUIM: Drug Utilization Quality Indicator Meeting. WHO, Mechelen
29. JL Hoven FM Haaijer-Ruskamp RH Vander Stichele 2005 Indicators of prescribing quality in drug utilisation research: report of a European meeting (DURQUIM, 13-15 May 2004) Eur J Clin Pharmacol 60 11 831 834 10.1007/s00228-004-0845-x 1:STN:280:DC%2BD2M%2Fjt1yrtQ%3D%3D 15592823 (Pubitemid 40394577)
30. Socialstyrelsen (2003) Indikatorer för utvärdering av kvaliteten I äldres läkemedelsterapi-socialstyrelsens förslag. Stockholm
31. Naturhistoriska riksmuseet (2007) Årets pollensäsong-nu börjar det! Available at: htwww.nrm.se/sv/menss/ pressmeddelandessmeddelanden/200t spollensasongnuborjardet.1374.html
32. PO Ehrs M Nokela B Stallberg P Hjemdahl E Wikstrom Jonsson 2006 Brief questionnaires for patient-reported outcomes in asthma: validation and usefulness in a primary care setting Chest 129 4 925 932 10.1378/chest.129.4.925 16608940
33. S Kamble M Bharmal 2009 Incremental direct expenditure of treating asthma in the United States J Asthma 46 1 73 80 10.1080/02770900802503107 19191142
34. Läkemedelsverket (2002) Bakgrukumentation-akologisk ndling av astma (database on the Internet). Available at: http://www.lakemedelsverket.se/upload/ Hälso-%20och%20sjukvård/behandlingsrek/bakg-dok/astma-bakgrund.pdf
35. ML Osborne WM Vollmer KL Linton AS Buist 1998 Characteristics of patients with asthma within a large HMO: a comparison by age and gender Am J Respir Crit Care Med 157 1 123 128 1:STN:280:DyaK1c7gs1SltQ%3D%3D 9445289
36. P Weiner R Magadle F Massarwa M Beckerman N Berar-Yanay 2002 Influence of gender and inspiratory muscle training on the perception of dyspnea in patients with asthma Chest 122 1 197 201 10.1378/chest.122.1.197 12114358 (Pubitemid 34754162)
37. Abraham B, Antó JM, Barreiro E, Bel EHD, Bousquet J, Castellsagud J, et al (2003) The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J 22(3):470-477
38. GB Diette AW Wu EA Skinner L Markson RD Clark RC McDonald, et al. 1999 Treatment patterns among adult patients with asthma: factors associated with overuse of inhaled beta-agonists and underuse of inhaled corticosteroids Arch Intern Med 159 22 2697 2704 10.1001/archinte.159.22.2697 1:STN:280: DC%2BD3c%2FmsVKgsg%3D%3D 10597760
39. DW Cockcroft BE Davis 2006 Airway hyperresponsiveness as a determinant of the early asthmatic response to inhaled allergen J Asthma. 43 3 175 178 10.1080/02770900600566348 1:CAS:528:DC%2BD28XjtlKqsLY%3D 16754517 (Pubitemid 43879408)
40. M Hasselgren M Arne A Lindahl S Janson B Lundback 2001 Estimated prevalences of respiratory symptoms, asthma and chronic obstructive pulmonary disease related to detection rate in primary health care Scand J Prim Health Care 19 1 54 57 10.1080/028134301300034701 1:STN:280:DC%2BD3MvntlWiug%3D%3D 11303549
41. Nilsson JLG, Haupt D, Krigsman K, Moen J (2009) Asthma/COPD drugs reflecting disease prevalence, patient adherence and persistence. Expert Review (serial on the Internet)
42. R Beasley FD Martinez A Hackshaw KF Rabe PJ Sterk R Djukanovic 2009 Safety of long-acting beta-agonists: urgent need to clear the air remains Eur Respir J 33 1 3 5 10.1183/09031936.00163408 1:STN:280:DC%2BD1M%2FkslWktg%3D%3D 19118222
43. CJ Cates MJ Cates TJ Lasserson 2008 Regular treatment with formoterol for chronic asthma: serious adverse events Cochrane Database Syst Rev 4 CD006923 18843738
44. GINA Guidelines. (2008) Pocket guide for asthma management and prevention 2008: Available at: http://www.ginasthma.com/Guidelineitem.asp?l1=2&l2= 1&intId=1562
45. CM Ni IR Greenstone FM Ducharme 2005 Addition of inhaled long-acting beta2- agonists to inhaled steroids as first line therapy for persistent asthma in steroid- naive adults Cochrane Database Syst Rev 2 CD005307 15846751
46. MR Partridge LM Fabbri KF Chung 2000 Delivering effective asthma care-how do we implement asthma guidelines? Eur Respir J 15 2 235 237 10.1034/j.1399-3003.2000.15b01.x 1:STN:280:DC%2BD3c7mvFSjsg%3D%3D 10706483 (Pubitemid 30085944)
47. S Wiener-Ogilvie G Huby H Pinnock J Gillies A Sheikh 2008 Practice organisational characteristics can impact on compliance with the BTS/SIGN asthma guideline: qualitative comparative case study in primary care BMC Fam Pract 9 32 10.1186/1471-2296-9-32 18533013 (Pubitemid 351840934)
48. MP Eccles J Soutter DN Bateman M Campbell JM Smith 1996 Influences on prescribing in non-fundholding general practices Br J Gen Pract 46 406 287 290 1:STN:280:DyaK283pslygsA%3D%3D 8762744 (Pubitemid 26154830)
49. M Mansouri J Lockyer 2007 A meta-analysis of continuing medical education effectiveness J Contin Educ Health Prof 27 1 6 15 10.1002/chp.88 17385735
50. LA Bero R Grilli JM Grimshaw E Harvey AD Oxman MA Thomson 1998 Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group Br Med J 317 7156 465 468 1:STN:280:DyaK1czmvV2htQ%3D%3D
51. DM Taylor TE Auble WJ Calhoun VN Mosesso Jr 1999 Current outpatient management of asthma shows poor compliance with International Consensus Guidelines Chest 116 6 1638 1645 10.1378/chest.116.6.1638 1:STN:280: DC%2BD3c%2Fmt1Kjsg%3D%3D 10593788
52. JM Grimshaw RE Thomas G MacLennan C Fraser CR Ramsay L Vale, et al. 2004 Effectiveness and efficiency of guideline dissemination and implementation strategies Health Technol Assess 8 6 1
53. MM Brown GC Brown S Sharma H Hollands AF Smith 2001 Physician manpower and health care expenditures in the United States: a thirty-year perspective J Health Care Finance 27 4 55 64 1:STN:280:DC%2BD3MznslKksA%3D%3D 11434713
54. Folland S, Goodman A, Stano M (eds) (2004) The ecoonomics of health and health care. Pearson Prentice Hall, Upper Saddle River
55. Leonard C, Stordeur S, Roberfroid D (2009) Association between physician density and health care consumption: A systematic review of the evidence. Health Policy 91:121-34
56. R Grol J Grimshaw 2003 From best evidence to best practice: effective implementation of change in patients' care Lancet 362 9391 1225 1230 10.1016/S0140-6736(03)14546-1 14568747 (Pubitemid 37255352)
57. R Grol M Wensing 2004 What drives change? Barriers to and incentives for achieving evidence-based practice Med J Aust 180 6 Suppl S57 S60 15012583
58. B Wettermark K Haglund LL Gustafsson PM Persson U Bergman 2005 A study of adherence to drug recommendations by providing feedback of outpatient prescribing patterns to hospital specialists Pharmacoepidemiol Drug Saf 14 8 579 588 10.1002/pds.1098 15818639 (Pubitemid 41179488)
59. JP Wisnivesky J Lorenzo R Lyn-Cook T Newman A Aponte E Kiefer, et al. 2008 Barriers to adherence to asthma management guidelines among inner-city primary care providers Ann Allergy Asthma Immunol 101 3 264 270 18814449
60. GM Cochrane R Horne P Chanez 1999 Compliance in asthma Respir Med 93 11 763 769 10.1016/S0954-6111(99)90260-3 1:STN:280:DC%2BD3c%2FntFakuw%3D%3D 10603624
61. M Lindberg T Ekstrom M Moller J Ahlner 2001 Asthma care and factors affecting medication compliance: the patient's point of view Int J Qual Health Care 13 5 375 383 10.1093/intqhc/13.5.375 1:STN:280:DC%2BD3Mrms1aguw%3D%3D 11669565 (Pubitemid 32962924)
62. B Stallberg U Nystrom Kronander P Olsson L Gottberg E Ronmark B Lundback 2003 Living with asthma in Sweden-the ALMA study Respir Med 97 7 835 843 10.1016/S0954-6111(03)00040-4 1:STN:280:DC%2BD3szisVynsw%3D%3D 12854635 (Pubitemid 36773142)
63. K Krigsman A Melander A Carlsten A Ekedahl JL Nilsson 2007 Refill non-adherence to repeat prescriptions leads to treatment gaps or to high extra costs Pharm World Sci 29 1 19 24 10.1007/s11096-005-4797-8 17268941 (Pubitemid 46295171)